Related Experiment Video
Updated: Jul 13, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Pfnek3 functions as an atypical MAPKK in Plasmodium falciparum
Huiyu Low1, Yu Min Lye, Tiow-Suan Sim
1Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, MD4A, 5 Science Drive 2, Singapore 117597, Singapore.
Abstract:
Eukaryotes generally rely on signal transduction by mitogen-activated protein kinases (MAPKs) for activating their regulatory pathways. However, the presence of a complete MAPK cascade in Plasmodium falciparum is debatable because a search of the entire genome did not portray known MAPK kinase (MAPKK) sequences. Via homology PCR experiments, only two copies of plasmodial MAPK homologues (Pfmap1 and Pfmap2) have been identified but their upstream activators remain unknown. In an earlier experiment, Pfnek3 was found to be an unusual activator of Pfmap2 in in vitro experiments, despite its molecular identity as a malarial protein kinase from the NIMA (Never in Mitosis, Aspergillus) family. In this study, the role of Pfnek3 as a likely upstream MAPKK is defined through molecular and biochemical characterization. Since a previous report proposes a TSH motif as an activation site of Pfmap2, its site-directed mutants, T290A, S291A, and H292K were constructed to elucidate the involvement of Pfnek3 in phosphorylating and activating Pfmap2 in a battery of kinase assays. The results suggested that residue T290 is the site of phosphorylation by Pfnek3. This supposition was further supported by liquid chromatography mass spectrometry. Although P. falciparum does not appear to possess a conventional MAPK cascade, they may rely on other kinases such as Pfnek3 to carry out similar phosphorylation to activate its signaling pathways.
Insights
Plasmodium falciparum may use Pfnek3, a malarial protein kinase, to activate signaling pathways. Pfnek3 phosphorylates Pfmap2 at residue T290, suggesting a non-conventional mitogen-activated protein kinase (MAPK) cascade.
Area of Science:
- Molecular parasitology
- Signal transduction pathways
- Protein kinase function
Background:
- Eukaryotic cells utilize mitogen-activated protein kinases (MAPKs) for regulatory pathway activation.
- The malaria parasite Plasmodium falciparum lacks canonical MAPK cascade components, including known MAPK kinase (MAPKK) sequences.
- Two Plasmodium falciparum MAPK homologues (Pfmap1 and Pfmap2) have been identified, but their upstream activators are unknown.
Purpose of the Study:
- To biochemically and molecularly characterize the role of Pfnek3 as a potential upstream MAPKK in Plasmodium falciparum.
- To investigate the phosphorylation site and activation mechanism of Pfmap2 by Pfnek3.
Main Methods:
- Homology PCR to identify plasmodial MAPK homologues.
- Site-directed mutagenesis of Pfmap2 (T290A, S291A, H292K) based on a proposed TSH activation motif.
- Kinase assays to assess Pfnek3's phosphorylation activity on Pfmap2 and its mutants.
- Liquid chromatography-mass spectrometry to confirm phosphorylation sites.
Main Results:
- Pfnek3 was confirmed as an unusual activator of Pfmap2.
- Residue T290 of Pfmap2 was identified as the primary site of phosphorylation by Pfnek3.
- Mutagenesis studies supported the role of T290 in Pfnek3-mediated activation of Pfmap2.
- Mass spectrometry validated T290 as the phosphorylation site.
Conclusions:
- Plasmodium falciparum may employ non-conventional kinases like Pfnek3 to mediate signaling pathway activation, mimicking MAPK cascade functions.
- Pfnek3 acts as an upstream kinase, phosphorylating Pfmap2 at T290, suggesting a unique signaling mechanism in the parasite.
- This study elucidates a novel aspect of signal transduction in Plasmodium falciparum, despite the absence of a canonical MAPK pathway.
Related Concept Videos
Malaria
MAPK Signaling Cascades
Diversity of Protists II

